NCT07030712
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07030712
Title A Clinical Study of MK-8294 in Participants With Advanced Solid Tumors (MK-8294-001)
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Merck Sharp & Dohme LLC
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | NLD | ISR

Facility Status City State Zip Country Details
Northwestern University ( Site 0101) RECRUITING Chicago Illinois 60611 United States Details
Rambam Health Care Campus ( Site 0201) RECRUITING Haifa 3109601 Israel Details
Sheba Medical Center ( Site 0200) RECRUITING Ramat Gan 5265601 Israel Details
Radboudumc ( Site 0301) RECRUITING Nijmegen Gelderland 6525 GA Netherlands Details
Nederlands Kanker Instituut - Antoni van Leeuwenhoek - NKI-AVL ( Site 0300) RECRUITING Amsterdam North Holland 1066 CX Netherlands Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field